Clinical Trial of Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Healthy Adults
- Status
- UNKNOWN
- Phase
- PHASE4
Clinical Trials Related to COVID-19
Related studies linked through entity extraction aliases.
EPIC-HR: Study of Oral PF-07321332/Ritonavir Compared With Placebo in Nonhospitalized High Risk Adults With COVID-19
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
To Evaluate the Safety, Tolerability, Efficacy and Immunogenicity of BNT162b2 Boosting Strategies Against COVID-19 in Participants ≥12 Years of Age.
- Status
- COMPLETED
- Phase
- PHASE3
Immunogenicity and Safety Study of Adjuvanted SARS-CoV-2 (SCB-2019) Vaccine in Adultsin China
- Status
- UNKNOWN
- Phase
- PHASE2
Immunogenicity and Safety of an Inactivated COVID-19 Vaccine
- Status
- COMPLETED
- Phase
- PHASE4
Effect of Tumor Treating Fields (TTFields, 150 kHz) Concomitant With Best Standard of Care for the Treatment of Hospitalized COVID-19 Patients and Continued Treatment Following Discharge
- Status
- COMPLETED
- Phase
- NA
Study on Sequential Immunization of Inactivated COVID-19 Vaccine and Recombinant COVID-19 Vaccine (Ad5 Vector) in Elderly Adults
- Status
- COMPLETED
- Phase
- PHASE4
Acupuncture Therapy for COVID-Related Olfactory Loss
- Status
- COMPLETED
- Phase
- NA
Clinical, Molecular and Functional Biomarkers for PROgnosis, Pathomechanisms and Treatment Strategies of COVID-19 (PROVID) - (PROVID-CAPNETZ)
- Status
- UNKNOWN
- Phase
- N/A
A Randomised-controlled Trial of an Oral Microbiome Immunity Formula in Recovered COVID-19 Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Immunogenicity and Safety of Adjuvanted SCB-2020S Vaccines in Adults
- Status
- WITHDRAWN
- Phase
- PHASE2
A Trial Investigating the Safety and Effects of One or Two Additional Doses of Comirnaty or One Dose of BNT162b2s01 in BNT162-01 or BNT162-04 Trial Subjects
- Status
- COMPLETED
- Phase
- PHASE2
Rapid Acceleration for Diagnostics in Underserved Populations: Home Testing
- Status
- COMPLETED
- Phase
- N/A
Cognitive Training and Brain Stimulation in Patients With Post-COVID-19 Cognitive Impairment
- Status
- COMPLETED
- Phase
- NA
Change in Antibody Levels Following SARS-CoV-2 (Covid-19) Vaccinations
- Status
- UNKNOWN
- Phase
- N/A
The Role of Chlorhexidine in Minimizing the Viral Load Among COVID-19 Patients
- Status
- COMPLETED
- Phase
- PHASE4
Support for the Resumption of Training of High-level Athletes Post-epidemic COVID-19
- Status
- COMPLETED
- Phase
- NA
Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19
- Status
- UNKNOWN
- Phase
- PHASE3
Safety and Immunogenicity of LNP-nCOV saRNA-02 Vaccine Against SARS-CoV-2, the Causative Agent of COVID-19
- Status
- UNKNOWN
- Phase
- PHASE1
Comparison of COVID-19 and H1N1 Influenza Pneumonia
- Status
- COMPLETED
- Phase
- N/A